A Multicenter, Open-label, Phase 2 Study of Imprime PGG and Pembrolizumab in Patients with Metastatic Breast Cancer (mBCA) Who Have Progressed Through Prior Hormonal Therapy
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Treatment
Locations
CTRC Inpatient
Lone Tree Medical Center
University of Colorado Hospital
Study ID
Protocol Number: 21-5099
More information available at ClinicalTrials.gov: NCT05159778
Categories
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers